Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.

Davidson MH, Voogt J, Luchoomun J, Decaris J, Killion S, Boban D, Glass A, Mohammad H, Lu Y, Villegas D, Neese R, Hellerstein M, Neff D, Musliner T, Tomassini JE, Turner S.

Atherosclerosis. 2013 Oct;230(2):322-9. doi: 10.1016/j.atherosclerosis.2013.08.006. Epub 2013 Aug 13.

PMID:
24075764
2.

Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.

Els√łe S, Christoffersen C, Luchoomun J, Turner S, Nielsen LB.

Biochim Biophys Acta. 2013 Jul;1831(7):1287-92.

PMID:
24046869
3.

In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Holleboom AG, Jakulj L, Franssen R, Decaris J, Vergeer M, Koetsveld J, Luchoomun J, Glass A, Hellerstein MK, Kastelein JJ, Hovingh GK, Kuivenhoven JA, Groen AK, Turner SM, Stroes ES.

J Lipid Res. 2013 Jul;54(7):1964-71. doi: 10.1194/jlr.P028449. Epub 2013 May 6.

4.

Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion.

Turner S, Voogt J, Davidson M, Glass A, Killion S, Decaris J, Mohammed H, Minehira K, Boban D, Murphy E, Luchoomun J, Awada M, Neese R, Hellerstein M.

J Am Heart Assoc. 2012 Aug;1(4):e001826. doi: 10.1161/JAHA.112.001826. Epub 2012 Aug 24.

5.

How a walk and talk in the park helped to relieve depression.

Luchoomun J.

Nurs Stand. 2010 May 19-25;24(37):29. No abstract available.

PMID:
20533666
6.

5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Amar MJ, D'Souza W, Turner S, Demosky S, Sviridov D, Stonik J, Luchoomun J, Voogt J, Hellerstein M, Sviridov D, Remaley AT.

J Pharmacol Exp Ther. 2010 Aug;334(2):634-41. doi: 10.1124/jpet.110.167890. Epub 2010 May 19.

7.

A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases.

Luyendyk JP, Piper JD, Tencati M, Reddy KV, Holscher T, Zhang R, Luchoomun J, Chen X, Min W, Kunsch C, Mackman N.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1857-63. Epub 2007 Jun 7.

PMID:
17561491
8.

AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression.

Kunsch C, Luchoomun J, Chen XL, Dodd GL, Karu KS, Meng CQ, Marino EM, Olliff LK, Piper JD, Qiu FH, Sikorski JA, Somers PK, Suen KL, Thomas S, Whalen AM, Wasserman MA, Sundell CL.

J Pharmacol Exp Ther. 2005 May;313(2):492-501. Epub 2005 Feb 8.

PMID:
15701708
9.

Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.

Meng CQ, Somers PK, Hoong LK, Zheng XS, Ye Z, Worsencroft KJ, Simpson JE, Hotema MR, Weingarten MD, MacDOnald ML, Hill RR, Marino EM, Suen KL, Luchoomun J, Kunsch C, Landers LK, Stefanopoulos D, Howard RB, Sundell CL, Saxena U, Wasserman MA, Sikorski JA.

J Med Chem. 2004 Dec 2;47(25):6420-32.

PMID:
15566311
10.

Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.

Murata S, Sundell CL, Lijkwan MA, Balsam LB, Hammainen P, Coleman C, York C, Luchoomun J, Suen KL, Howard R, Somers PK, Morris RE, Robbins RC.

Transplantation. 2004 May 27;77(10):1494-500.

PMID:
15239610
11.

Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent.

Kunsch C, Luchoomun J, Grey JY, Olliff LK, Saint LB, Arrendale RF, Wasserman MA, Saxena U, Medford RM.

J Pharmacol Exp Ther. 2004 Mar;308(3):820-9. Epub 2003 Nov 14.

PMID:
14617690
13.

Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins.

Nion S, Demoor L, Boutillon C, Luchoomun J, Vanloo B, Fievet C, Castro G, Rosseneu M, Fruchart JC, Tartar A, Clavey V.

Atherosclerosis. 1998 Dec;141(2):227-35.

PMID:
9862171
14.
15.

Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA.

Luchoomun J, Zhou Z, Bakillah A, Jamil H, Hussain MM.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2955-63.

PMID:
9409282
16.

Measurement of apolipoprotein B in various cell lines: correlation between intracellular levels and rates of secretion.

Bakillah A, Zhou Z, Luchoomun J, Hussain MM.

Lipids. 1997 Oct;32(10):1113-8.

PMID:
9358438
17.

Chylomicron assembly and catabolism: role of apolipoproteins and receptors.

Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, Bakillah A.

Biochim Biophys Acta. 1996 May 20;1300(3):151-70. Review.

PMID:
8679680
18.

Structural domain of apolipoprotein A-I involved in its interaction with cells.

Luchoomun J, Theret N, Clavey V, Duchateau P, Rosseneu M, Brasseur R, Denefle P, Fruchart JC, Castro GR.

Biochim Biophys Acta. 1994 Jun 2;1212(3):319-26.

PMID:
7515279

Supplemental Content

Loading ...
Support Center